The Southern Philippines Medical Center is a government hospital under the Department of Health of the Republic of the Philippines. It is located at the JP Laurel Ave, Bajada, Davao City. It began as the Davao Medical Center. Its name was changed on November 19, 2009 by Republic Act 9792.

There are 1,453 beds in Southern Philippines Medical Center.

During the past decade, Southern Philippines Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Philippines Medical Center" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Boston Pharmaceuticals" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Fresenius Kabi" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Philippines Medical Center" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Southern Philippines Medical Center" are "Systemic Lupus Erythematosus" (4 trials), "Generalized Pustular Psoriasis" (2 trials), "Lupus Nephritis" (2 trials), "Arthritis, Psoriatic" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Southern Philippines Medical Center" in a lesser frequency.

Most popular intervention types in "Southern Philippines Medical Center" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Baricitinib" (2 trials), "Spesolimab" (2 trials), "BI 655064" (1 trials) and "BI 655064 dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Philippines Medical Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Southern Philippines Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Southern Philippines Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Philippines Medical Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".